09:45 AM EST - Valeant Pharmaceuticals International, Inc. : and Ideal Implant Incorporated today announced the receipt of approval from the U.S. Food and Drug Administration (FDA) and Health Canada to market the IDEAL IMPLANT® Saline-filled Breast Implant for use in primary breast augmentation or replacement of existing augmentation implants. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $1.67 at $156.07.
